Krishna Institute of Medical Sciences Intrinsic Value
KIMS Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹186.04 | ₹148.83 - ₹223.25 | -70.0% | EPS: ₹6.68, Sector P/E: 12x |
| Book Value Method | asset | ₹302.38 | ₹272.14 - ₹332.62 | -51.2% | Book Value/Share: ₹302.38, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹386.00 | ₹347.40 - ₹424.60 | -37.8% | Revenue/Share: ₹482.50, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹565.37 | ₹508.83 - ₹621.91 | -8.8% | EBITDA: ₹832.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹919.80 | ₹735.84 - ₹1103.76 | +48.3% | CF Growth: 13.1%, Discount: 15% |
| PEG Ratio Method | growth | ₹186.04 | ₹167.44 - ₹204.64 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹186.04 | ₹167.44 - ₹204.64 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹432.00 | ₹388.80 - ₹475.20 | -30.3% | ROE: 11.9%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹213.18 | ₹191.86 - ₹234.50 | -65.6% | EPS: ₹6.68, BVPS: ₹302.38 |
Want to compare with current market value? Check KIMS share price latest .
Valuation Comparison Chart
KIMS Intrinsic Value Analysis
What is the intrinsic value of KIMS?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Krishna Institute of Medical Sciences (KIMS) is ₹302.38 (median value). With the current market price of ₹620.15, this represents a -51.2% variance from our estimated fair value.
The valuation range spans from ₹186.04 to ₹919.80, indicating ₹186.04 - ₹919.80.
Is KIMS undervalued or overvalued?
Based on our multi-method analysis, Krishna Institute of Medical Sciences (KIMS) appears to be trading above calculated value by approximately 51.2%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.28 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 2.37 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 11.9% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 21.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.67x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Krishna Institute of Medical Sciences
Additional stock information and data for KIMS
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹582 Cr | ₹24 Cr | Positive Free Cash Flow | 7/10 |
| March 2024 | ₹521 Cr | ₹145 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹432 Cr | ₹224 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹324 Cr | ₹118 Cr | Positive Free Cash Flow | 7/10 |
| March 2021 | ₹356 Cr | ₹179 Cr | Positive Free Cash Flow | 8/10 |